Johnson & Johnson (NYSE:JNJ) went down by -0.66% from its latest closing price when compared to the 1-year high value of $154.50 and move down -2.94%, while JNJ stocks collected -2.24% of loss with the last five trading sessions. Press Release reported on 02/12/20 that Johnson & Johnson to Participate in the 9th Annual SVB Leerink Global Healthcare Conference

Johnson & Johnson (NYSE:JNJ) Worth an Investment?

Johnson & Johnson (NYSE: JNJ) scored price to earnings ratio above its average ratio, recording 26.96 times of increase in earnings at the present.

JNJ Market Performance

JNJ stocks went down by -2.24% for the week, with the monthly jump of 2.44% and a quarterly performance of 14.27%, while its annual performance rate touched 11.63%. The simple moving average for the period of the last 20 days is -0.04% for JNJ stocks with the simple moving average of 9.59% for the last 200 days.

Analysts’ Opinion on Johnson & Johnson (NYSE:JNJ)

Many brokerage firms have already submitted their reports for JNJ stocks, with Barclays repeating the rating for JNJ shares by setting it to “Overweight”. The predicted price for JNJ socks in the upcoming period according to Barclays is $173 based on the research report published on December 19, 2019.

Morgan Stanley, on the other hand, stated in their research note that they expect to see JNJ stock at the price of $170, previously predicting the value of $145. The rating they have provided for JNJ stocks is “Overweight” according to the report published on December 17, 2019.

Cantor Fitzgerald gave “Overweight” rating to JNJ stocks, setting the target price at $160 in the report published on November 20, 2019.

JNJ Stocks 2.76% Far from 50 Day Moving Average

After a stumble in the market that brought JNJ to its low price for the period of the last 52 weeks, Johnson & Johnson was unable to take a rebound, for now settling with -2.85% of loss for the given period.

The stock volatility was left at 1.16%, however, within the period of a single month, the volatility rate increased by 0.82%, while the shares surge at the distance of +2.10% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +9.27% upper at the present time.

In the course of the last 5 trading sessions, JNJ went down by -2.24%, which changed the moving average for the period of 200 days to the total of +6.30% of gains for the stock in comparison to the 20-day moving average settled at $150.30. In addition, Johnson & Johnson saw 2.89% in overturn over the period of a single year with a tendency to cut further gains.

JNJ Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at Johnson & Johnson (JNJ), starting from Sneed Michael E, who sold 58,128 shares at the price of $149.39 back on Jan 30. After this action, Rushing now owns 49,383 shares of Johnson & Johnson, valued at $8,683,568 with the latest closing price.

Joly Hubert, the Director of Johnson & Johnson, bought 5,000 shares at the value of $141.28 during a trade that took place back on Dec 13, which means that Joly Hubert is holding 5,000 shares at the value of $706,399 based on the most recent closing price.

JNJ Stock Fundamentals

The current profitability levels are settled at +25.55 for the present operating margin and +71.94 for gross margin. The net margin for Johnson & Johnson stands at +18.42. Equity return holds the value 27.50%, with 10.60% for asset returns.